Publications by authors named "C Finocchi"
Background: Migraine is a highly underestimated and burdensome disease. Real-world studies evidence that migraine is more frequent and severe in women than men. However, to this day, no diagnostic-therapeutic pathways exist to satisfy the specific needs of female patients.
View Article and Find Full Text PDFArticle Synopsis
- A 48-week study assessed the effectiveness and safety of fremanezumab in patients with high-frequency episodic migraine (HFEM) or chronic migraine (CM) who had experienced more than three treatment failures.* -
- Results showed significant reductions in monthly migraine days (HFEM -6.4; CM -14.5) and monthly analgesic medication usage, along with improvements in pain and disability scores, across the majority of participants.* -
- Response rates to treatment indicated that a substantial number of patients experienced significant reductions in migraine frequency, with 75.5% achieving at least a 50% reduction in HFEM and 71.6% in CM.*